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Summary
Migraine is a chronic, debilitating condition that
affects scores of individuals each day.
Remarkably, a new study has demonstrated that
mutations in the neuronal calcium channel Cav2.1
are the molecular basis for migraine headaches
Introduction
Migraine headache is a common, chronic, debilitating
pain that affects roughly 6-8% of men and 15-18% of
women in the U.S. and Europe (WHO, 2004).  In the
U.S., the annual cost of migraine treatment ranges from
13-17 billion dollars (Goldberg, 2005; Blumenfeld,
2005).  Often it causes deficits in cognition, function,
and sleep.  Until recently, no research had defined the
molecular basis for such a widespread illness.
However, a remarkable study conducted by
Maagdenberg and colleagues (2004) suggested that
mutations in a gene encoding neuronal calcium
channels were the molecular basis for migraine.
The different types of migraine headaches
are distinguished by their symptoms.  The known
genetic form of migraine is called Familial Hemiplegic
Migraine (FHM).  It is characterized by an aura
beginning 10-30 minutes before head pain.  The aura
can consist of hallucinations, visual impairments,
hearing malfunctions, etc.  Cortical spreading
depression (CSD), consisting of sharp increases in
neuron excitability followed by a depression in activity,
has been known to be a precursor to aura (Hadjikhani
et al., 2001; Gursoy-Ozdemir et al., 2004).
At the molecular level, many types of
transmembrane protein channels allow various ionic
species to travel into and out of the cell.  Specifically,
upon depolarization of the cell, calcium channels
release a large influx of calcium ions into the cell which
bind and release neurotransmitter vesicles.  Calcium
ion channels regulate this crucial event in synaptic
transmission and are composed of numerous proteins
(subunits) that work together to form a single entity.
FHM results from mutations within the
Cacna1a gene and is autosomal dominant. This gene
encodes the alpha subunit of a specific calcium channel
Cav2.1.  It has been suggested that mutations in this
gene cause FHM to occur, making it a prime target for
research (Tottene et al., 2002; Jun and Piedras-
Renteria, 1999).
Prior to the research done by Maagdenberg
and colleagues (2004), there was a significant
contradiction in regards to mutated Cav2.1 activity.
Several previous studies have been conducted on
Cav2.1 channels with mutations in the Cacna1a gene.
One study used cells that were heterozygous for the
mutant Cav2.1 channel alpha subunit (Maagdenberg et
al., 2004).  Their data showed individual channels
conducted increased amounts of calcium ions from the
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outside to the inside of the cell.  Another group studied
Cav2.1 at the whole cell level instead of individual
channels and found that the Cav2.1 channels had a
decrease in conductivity at the whole cell level (Tottene
et al., 2002).
These two contradictory findings highlight the
previous gaps in knowledge.  It was unknown whether a
mutation in the Cacna1a gene leads to a gain of
function or a loss of function in the Cav2.1 channels,
and if this mutation triggers CSD and aura.  To fill these
gaps, three experiments were performed using a
mouse homozygous for the mutated form of Cacna1a.
Maagdenberg and colleagues (2004) expressed
the mutated channel in cerebellar granule cells and
found that they opened and conducted more calcium
ions into the cell at a lower voltage.  The implications of
these results are significant because an increase in
calcium would cause an increase in neurotransmitter
release and potentially hyper-excitability of the neuron.
The next step in this study made use of the
neuromuscular junction, located at the synapse
between motor neuron and skeletal muscle.  The
concentration of extracellular calcium ions was varied to
observe whether the channels would release higher
levels of neurotransmitter at low extra-cellular calcium
concentration.  It was found that low extra-cellular
calcium lead to an elevated release of neurotransmitter
in Cacna1a knockin mice.
This finding suggested that the mutated Cav2.1
channels allow for an increased calcium influx and that
they cause more neurotransmitter release.  An increase
in neurotransmitter release causes transient neuronal
hyper-excitability and shows that there is increased
calcium influx and more release of neurotransmitter in
the migraine brain.  The only connection that has not
been made is that of increased neuronal excitability to
CSD and aura.
Maagdenberg and colleagues (2004) performed
three experiments to link the mutation in Cacna1a gene
to CSD and aura.  The first was a measure of the CSD
activation threshold, which is the amount of neuronal
activity that must be reached in order to trigger CSD.
They found the CSD threshold to be lower in mutants,
meaning that CSD could be triggered more easily in
mutants than in the wild-type.
Next, they tested for a change in the rate of
CSD propagation and duration.  The knockins were
found to have CSD propagation at a much higher speed
compared to the wild type.  This, along with the finding
that the CSD activation threshold was lower in the
knockins, revealed a clear link between the mutated
alpha-subunit and the precursor to aura, CSD.  When
the duration of CSD was analyzed, they found the
mutants to have increased CSD duration compared to
the wild-type.
The impacts of these findings are quite
significant to this field of study, because Maagdenberg
and colleagues (2004) found mutated Cav2.1 channels
to open at lower voltages, allowing for an increase in
calcium ion conductivity that triggers an increase in
neurotransmitter release.  Furthermore, this lowers the
activation threshold, rate of propagation, and duration
of CSD.  These experiments lay a simple map that
begins with a mutation in the alpha-subunit of the
calcium channel Cav2.1and ends in migraine (Figure
1).
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Figure 1:  Pathway showing the steps leading to migraine.
(Maagdenberg et al., 2004)
As a result of these findings, migraine
research can move toward developing better treatment
methods that affect or block one point in the pathway
further detailed by Maagdenberg and colleagues
(2004).  For those suffering from FHM, a viral vector
could be used to replace the defective gene and
alleviate chronic migraine pain.  Another possibility is
development of a drug that decreases Cav2.1 channel
activity and prevents CSD from developing and leading
to aura and migraine (Maagdenberg et al., 2004).
Though many different sub-types of
migraines exist, it is hopeful that these findings will
stimulate further research in the field and lead to
breakthrough treatments for this debilitating condition
that affects so many.
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